drugset / Trial / NCT06492512

Oral Iron Supplementation on Alternate vs. Consecutive Days for Iron Deficiency Anemia in Pregnancy

NCT06492512

Phase 4 Recruiting 120 enrolled Southern Illinois University
RandomizedParallel-groupOpen-labelTreatment

Summary

This will be a randomized clinical trial. Enrolled subjects will be randomized (1:1) into two study arms to receive either daily (Group 1) or alternate day (Group 2) supplementation with one oral pill containing ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill.

Timeline

Start
2025-05-27
Primary completion
2028-07-01
Completion
2029-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferrous Sulfate Diagnostic / imaging agent 65 mg Oral